44
S.-J. Liu et al. / Fitoterapia 97 (2014) 43–49
resources of Shanghai Institute of Life Science Chinese Academy
of Sciences. Tumor cells were incubated in an HF-212UV CO2
incubator and observed under an OLYMPUS CKX41 inverted
microscope. Optical density (OD) values were read under a
BIO-RAD Model 680 microplate reader. Cisplatin (HPLC N98%)
was purchased from the National Institutes for Food and Drug
Control. The purity of the two new sesquiterpenes (1: 99.84%;
2: 99.12%) was analyzed by HPLC (Agilent 1260: DEACA01043),
which was carried out on a column (Agilent ZORBAX SB-C18;
4.6 × 250 mm, 5 μm) using methanol and 0.1% glacial acetic
acid–water soln. (v/v 80/20) at a flow rate of 1 mL/min within
about 35 min.
gel (100 g, column: 2.5 × 100 cm) with a petroleum ether–
ethyl acetate gradient (v/v 8:1–2:1) to yield 28 (6.00 mg),
15 (105 mg), 23 (100 mg) and 4 (3.00 mg) while Fr.4.2 (10.6 g,
petroleum ether–ethyl acetate 2:1–1:1) was subjected to
separation repeated by silica gel (150 g, column: 3 × 100 cm)
column chromatography eluted with petroleum ether–ethyl
acetate (v/v 4:1–0:1) to yield 5 (200 mg), 11 (10.0 mg),
10 (305 mg) and 14 (4.00 mg). After that, a repeated separation
of the residue over Sephadex LH-20 with chloroform–methanol
(1:1) resulted in 6 (5.00 mg), 7 (3.00 mg), 8 (4.00 mg),
33 (3.00 mg) and 36 (6.00 mg). Concerning to Fr.5 (60.4 g,
petroleum ether-ethyl acetate 0:1), it was fractionated by
column chromatography over silica gel (600 g, column: 6 ×
100 cm) with the gradient system of increasing polarity with
chloroform–methanol (v/v 50:1–0:1). In this case, four frac-
tions (Fr.5.1–Fr.5.4, TCL data) were obtained. Compounds
19 (2.00 mg), 27 (2.00 mg), 25 (3.00 mg) and 24 (3.00 mg)
were subsequently eluted from Fr.5.1 (14.4 g, chloroform–
methanol 50:1–20:1) when eluted with a chloroform–methanol
of increasing polarity (v/v 50:1–10:1) by column chromatogra-
phy over silica gel (150 g, column: 4 × 100 cm), and com-
pounds 16 (4.00 mg), 1 (25.0 mg) and 17 (12.0 mg) were
precipitated successively from Fr.5.2 (20.6 g, chloroform–
methanol 10:1–8:1) with increasing polarity of chloroform–
methanol (v/v 12:1–7:1) by column chromatography over silica
gel (200 g, column: 5 × 100 cm). Fr.5.3 (13.8 g, chloroform–
methanol 6:1–4:1) was subjected to a silica gel column (150 g,
column: 4 × 100 cm) eluting with chloroform–methanol
(v/v 8:1–3:1) to yield 29 (15.0 mg), 2 (20.0 mg), 12 (15.0 mg)
and 13 (26.0 mg), while Fr.5.4 (13.4 g, chloroform–methanol
3:1–0:1) was further purified on silica gel (150 g, column:
4 × 100 cm) with chloroform–methanol (v/v 4:1–1:2) to give
18 (108 mg), 20 (11.0 mg), 30 (15.0 mg) and 21 (21.0 mg).
2.2. Plant material
The dried aerial parts of A. sieversiana were collected in July,
2012, Heka town of Xinghai County in Qinghai Province, China.
It was identified by Prof. Hong-Fa Sun of the Northwest Institute
of Plateau Biology, Chinese Academy of Sciences, Xining, China,
and a voucher specimen (No. 12-07-01) was deposited at the
laboratory of Zhi-Xin Liao, Southeast University, Nanjing, China.
2.3. Extraction and isolation
The dried and powdered plant material (2.40 kg) of
A. sieversiana was percolated four times (7 days each time)
with petroleum ether–Et2O–MeOH (1:1:1) (8 L × 4) at room
temperature. The filtrates were consolidated and evaporated
in vacuum to give a concentrate (204 g).
The resultant extract (204 g) was subjected to column
chromatography (CC) on silica gel (2000 g, column: 10 ×
100 cm) with a petroleum ether–ethyl acetate gradient
(v/v 50:1–0:1). Five crude fractions (Fr.1–Fr.5) were obtain-
ed, which were combined according to TLC data. Specifically,
Fr.1 (55.4 g, petroleum ether-ethyl acetate 50:1–20:1) was
discarded without further separation because it was mainly
comprised of volatile oil components of low polarity. Fr.2
(25.4 g, petroleum ether–ethyl acetate 10:1–8:1) was
further separated by column chromatography over silica gel
(250 g, column: 5 × 100 cm) with a petroleum ether–ethyl
acetate gradient (v/v 20:1–4:1) to yield 22 (203 mg). For Fr.3
(6.70 g, petroleum ether–ethyl acetate 6:1–4:1), it was
rechromatographed over silica gel (100 g, column: 2.5 ×
100 cm) with petroleum ether–ethyl acetate (v/v 14:1–1:1)
mixtures to give two fractions (Fr.3.1–Fr.3.2, TCL data). In
detail, Fr.3.1 (2.10 g, petroleum ether–ethyl acetate, 14:1–
8:1) was further purified by column chromatography over
silica gel (40 g, column: 2 × 80 cm) with a petroleum ether–
ethyl acetate gradient (v/v 16:1–4:1) to yield 3 (3.00 mg) and 9
(5.00 mg) while Fr.3.2 (3.20 g, petroleum ether-ethyl acetate
6:1–1:1) being further separated over Sephadex LH-20 with
chloroform–methanol (2:1) to yield 31 (3.00 mg), 26 (4.00 mg)
and 32 (3.00 mg). In terms of Fr.4 (37.0 g, petroleum ether–
ethyl acetate 3:1–1:1), it was firstly purified over MCI GEL
eluted with 80% ethanol to remove the pigments. The remaining
materials were evaporated for further isolation. It (20.4 g)
was rechromatographed over silica gel (200 g, column: 5 ×
100 cm) with petroleum ether–ethyl acetate (v/v 6:1–1:1)
mixtures to give two fractions (Fr.4.1–Fr.4.2 TCL data). Fr.4.1
(5.40 g, petroleum ether–ethyl acetate 6:1–3:1) was further
separated by repeated column chromatography over silica
2.4. Compound characterization
2α,9α-dihydroxymuurol-3(4)-en-12-oic acid (1): Colorless
crystals (CHCl3–MeOH, 8:1), mp: 203–204 °C, Rf 0.60, silica gel
40 F254, CHCl3/MeOH (7:1), [α]20 = −75.3 (c = 1.00, MeOH),
D
IR (KBr):3400, 2920, 2880, 1700 cm−1
.
1H and 13C NMR
(DMSO) (see Table 1). HR-ESI-MS: m/z 267.1599 ([M − H]−,
C15H23O-4, calc. 267.1596).
13α-methyl-(5αH,6αH,7αH,8αH)-austricin 8-O-β-D-gluco-
pyranoside (2): white amorphous powder, mp: 306–307 °C, Rf
0.50, silica gel 40 F254, CHCl3/MeOH (7:1), [α]20 = +12.2
D
(c = 0.11, MeOH), IR (KBr): 3527, 1760, 1688, 1621 cm−1. 1H
and 13C NMR (DMSO) (see Table 1), HR-ESI-MS: m/z 425.1809
([M + H]+, C21H29O+9 , calc. 425.1813).
2.5. Cytotoxicity experiments
The cytotoxicity effects of compounds 1–2 against MCF-7,
NCI-H460 and Hep-G2 cells were tested using the MTT
(3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bro-
mide) assay, and Cisplatin was used as a positive control.
The cell suspensions were distributed into 96-well cell
culture plates and cultured at 36–37 °C in a 5% CO2 incubator
for 24 h and each sample was dissolved with a limited
amount of DMSO, diluted to five different concentrations
with a culture medium and then added to the corresponding
well. The blank controls consisting of microbial culture were